Peroxisomal membrane permeability and solute transfer  by Antonenkov, Vasily D. & Hiltunen, J. Kalervo
Biochimica et Biophysica Acta 1763 (2006) 1697–1706
www.elsevier.com/locate/bbamcrReview
Peroxisomal membrane permeability and solute transfer
Vasily D. Antonenkov ⁎, J. Kalervo Hiltunen ⁎
Department of Biochemistry and Biocenter Oulu, University of Oulu, P.O. Box 3000, FIN-90014 Oulu, Finland
Received 26 April 2006; received in revised form 16 August 2006; accepted 18 August 2006
Available online 1 September 2006Abstract
The review is dedicated to recent progress in the study of peroxisomal membrane permeability to solutes which has been a matter of debate for
more than 40 years. Apparently, the mammalian peroxisomal membrane is freely permeable to small solute molecules owing to the presence of
pore-forming channels. However, the membrane forms a permeability barrier for ‘bulky’ solutes including cofactors (NAD/H, NADP/H, CoA, and
acetyl/acyl-CoA esters) and ATP. Therefore, peroxisomes need specific protein transporters to transfer these compounds across the membrane.
Recent electrophysiological studies have revealed channel-forming activities in the mammalian peroxisomal membrane. The possible involvement
of the channels in the transfer of small metabolites and in the formation of peroxisomal shuttle systems is described.
© 2006 Elsevier B.V. All rights reserved.Keywords: Peroxisome; Membrane permeability; Channel; Transporter1. Introduction
Peroxisomes are small oxidative organelles found in all
eukaryotes. Mammalian peroxisomes contain a matrix consist-
ing mainly of soluble proteins surrounded by a single membrane
composed of unique polypeptides and lipids. Little is known
about the function of peroxisomal membrane proteins. Some of
them are involved in the activation of fatty acids [1–3],
synthesis of ether glycerolipids [4,5] and waxes [6,7], cleavage
of membrane phospholipids [8,9] and antioxidative defense
[10–12]. Several membrane proteins are implicated in the
biogenesis of peroxisomes (reviewed in [13,14]). However, the
functions of the most abundant integral membrane proteins in
mammalian peroxisomes, e.g. rat liver peroxisomal proteins
with molecular masses of 18, 22, 24, 26, 35, 38, 70 and 74–
77 kDa [15–18], are still unknown.Abbreviations: VDAC, voltage-dependent anion channel; DHAP, dihydrox-
yacetonephosphate; ROS, reactive oxygen species; GSH, reduced glutathione;
GSSG, oxidized glutathione; ABC transporters, ATP binding cassette
transporters; NMN, nicotinamide mononucleotide
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doi:10.1016/j.bbamcr.2006.08.044The predominant phospholipids detected in the rat liver
peroxisomal membrane are choline- and ethanolamine-contain-
ing glycerophospholipids, which together represent 98% of the
total phospholipids. Both types of phospholipids contain a large
amount of polyunsaturated fatty acids, i.e. arachidonic acid,
20:4 and cervonic acid, 22:6 [8].
Due to the diversity of metabolic pathways in peroxisomes
(reviewed in [19–21]) these particles are apparently equipped with
sophisticated mechanisms that ensure the coordinated flow of diff-
erent metabolites across the boundary membrane. These mechan-
isms might rely on membrane channels freely accessible to solutes
and/or on specific transporters responsible for the transfer of
different compounds including lipid molecules. Curiously, until
now, our knowledge of the role of the peroxisomal membrane as a
permeability barrier to metabolic intermediates is very limited.
In the current review we discuss new developments in the study
of peroxisomalmembrane permeability and describe some putative
mechanisms governing metabolite flow across the membrane.
2. Permeability of the peroxisomal membrane to solutes
2.1. Does the peroxisomal membrane form a closed
compartment?
The functional role of the peroxisomal membrane as a
permeability barrier to metabolites has been a matter of
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have been discussed: (1) the membrane of peroxisomes contains
large nonselective channels and is freely permeable to solutes
reflecting the mechanism of permeation for the outer mito-
chondrial or nuclear membranes; (2) the peroxisomal membrane
is completely impermeable to small solute molecules and, like
the inner mitochondrial membrane, contains a set of selective
transporters. Both viewpoints have been supported by consid-
erable experimental evidence.
Early studies on mammalian peroxisomes conducted mainly
by De Duve and coworkers (reviewed in [22,23]) revealed that,
in contrast to mitochondrial and lysosomal enzymes, the
peroxisomal oxidases known at that time (urate oxidase, D-
amino acid oxidase, and L-α-hydroxyacid oxidase) did not
show any structure-linked latency in vitro, i.e. they are freely
accessible to substrates. This was later confirmed using
digitonin-permeabilized rat hepatocytes in attempts to avoid
disruption of peroxisomes during isolation [24]. The relatively
high equilibrium density of peroxisomes in sucrose and some
other (Nycodenz, Optiprep) gradients [25–27] is usually
regarded as an indication that the particles are readily permeable
to these gradient formers. A detailed in vitro study of the
permeability of rat liver peroxisomal membranes revealed rapid,
temperature-independent incorporation of radioactive com-
pounds (carnitine, sucrose, NAD+, ATP, etc.) into isolated
peroxisomes and leakage of radioactive sucrose from liposomes
reconstituted with peroxisomal membrane proteins [28]. These
findings led to the proposal that the membrane of peroxisomes
contains porin-like proteins, which are similar to the
corresponding proteins in the outer membranes of mitochondria
and chloroplasts [28].
On the other hand, several lines of evidence based mainly on
observations in situ showed that the membranes of peroxisomes
constitute a permeability barrier to at least some solutes. The
controversy surrounding the conflicting results obtained in vitro
and in vivo was frequently explained by the suggestion that the
properties of peroxisomal membranes before and after isolation
of the particles are not the same due to the well known high
fragility of peroxisomes (see, for example, ref. [21,29]).
Nevertheless, the initial reports challenging the ‘free-perme-
ability’ concept were based on in vitro experiments revealing
that some peroxisomal enzymes, e.g. glucose-6-phosphate
dehydrogenase [30] and acyl-CoA:dihydroxyacetonephosphate
(DHAP) acyltransferase [31] show structure-linked latency. In a
series of genetic studies on the yeast Saccharomyces cerevisiae,
Wanders and coworkers [32–34] described the involvement of
shuttle mechanisms in the functional relationships between
peroxisomes and other cellular compartments. The yeast
peroxisomal shuttles include malate/oxaloacetate [32] and
isocitrate/2-oxoglutarate [33,35] systems for re-oxidation of
NADH and reduction of NADP+, respectively, as well as an
acetylcarnitine shuttle [34]. Mammalian peroxisomes contain
several enzymes (lactate dehydrogenase, glucose-6-phosphate
dehydrogenase, NADP-dependent isocitrate dehydrogenase,
NAD-dependent glycerol-3-phosphate dehydrogenase, carni-
tine acetyl/acyltransferases), which can be considered as
intraperoxisomal components of the shuttle systems connectingperoxisomes with the cytoplasm and mitochondria (see Section
3.3 for more details). The existence of the shuttle systems has
generally been interpreted as a confirmation that the peroxi-
somal membrane is impermeable in vivo to low molecular mass
solutes. This viewpoint was strengthened by identification of
solute carriers related to the mitochondrial transporter super-
family in yeast [36,37] and mammalian [38] peroxisomes. Later
the proteins have been characterized functionally as peroxi-
somal ATP transporters [39–41].
Several attempts have been made to detect an apparent pH
gradient across yeast and mammalian peroxisomal membranes.
The existence of the gradient is widely considered to be a solid
confirmation that protons (H+) and hydroxyl ions (OH−) do not
move freely in and out of peroxisomes, which indicates the
presence of a membrane barrier. However, the results of the
experiments were highly contradictory. In situ measurements
have shown that the lumen of yeast peroxisomes is acidic [41–
43] or alkaline [44]. Targeting a pH-sensitive fluorescence
reporter group to peroxisomes in human fibroblasts led to
detection of the alkaline pH [45]. In contrast, measurements of
the pH using the fluorescent protein pHluorin, demonstrated
that in CHO cells the peroxisomal pH is neutral and the
peroxisomal membrane is highly permeable to protons [46].
The inconsistency in the results may indicate that the
intraperoxisomal pH is a dynamic parameter depending on the
physiological conditions in the cell. This is in line with the
prediction that the pH gradient between the peroxisomal lumen
and cytoplasm may be created (transiently or constantly) by the
mechanism known as a Donnan equilibrium [47] which governs
the behavior of mobile ions in the presence of charged
macromolecules surrounded by a semipermeable membrane.
To preserve electroneutrality, the equilibration of ions freely
crossing the membrane, including protons and hydroxyl ions,
will depend on the charge of the impermeable macromolecules
(i.e. proteins). For example, if the overall charge of proteins and
‘bulky’ solutes, e.g. cofactors and ATP (see Section 2.2)
confined to peroxisomes is more negative than in the
surrounding cytoplasm, the particles will attract small positively
charged ions, including protons, and repulse anions, including
hydroxyl ions, creating a transmembrane pH gradient.
2.2. ‘Two-channel’ concept of peroxisomal membrane
permeability
Based on our in vitro experiments on highly purified
peroxisomes we recently proposed a new concept of peroxi-
somal membrane permeability [48] that attempts to reconcile
the opposing viewpoints described in the previous section. Our
data indicate that the mammalian peroxisomal membrane is
freely permeable to solutes with molecular masses less than
300 Da, e.g. substrates for some peroxisomal oxidases (urate,
glycolate), while it heavily restricts permeation by compounds
comparable in size with cofactors (NAD/H, NADP/H, CoA and
its acylated derivatives). Therefore, in physiological terms the
peroxisomal membrane is open to small metabolites and at the
same time it is closed to cofactors and other ‘bulky’ solutes.
This observation led us to the conclusion that, in vivo,
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functionally independent from the corresponding pool of
cofactors in the cytoplasm. However, peroxisomes share a
common pool of small metabolites with the cytoplasm. To
explain this unusual feature of the particles we predicted the
existence of at least two types of pore-forming channels in the
peroxisomal membrane. The diameter of the one of these
channels is too small for molecules like cofactors, while the
other type of channels with a larger pore diameter allows slow
penetration of cofactors into peroxisomes. The relative quantity
of these channels in the membrane may explain the observed
difference between the rates of permeation to small metabolites
and cofactors, which exceeds 100-fold [48].
The ‘two-channel’ concept allows for the presence in
peroxisomal membranes of transporters specific for ‘bulky’
solutes, e.g. ATP antiporter [39–41], side by side with pore-
forming channels. However, these hypotheses obviate the need
for specific transporters for small solutes since these
compounds can cross the membrane by channels. Few
published observations are inconsistent with this conclusion.
The localization of transporters in mammalian peroxisomal
membranes that are specific for small metabolites (carnitine,
monocarboxylates, and phosphate) has been suggested
[49–51]. The carnitine-acylcarnitine carrier [49] and mono-
carboxylate transporter [50] have been detected in isolated
peroxisomal fractions using antibodies raised against the
corresponding mitochondrial proteins. Since purified peroxi-
somal preparations are always more or less contaminated by
mitochondria, the results of cell fractionation experiments
showing dual localization of a certain protein (mitochondria
and peroxisomes) are especially difficult to interpret. These
results need to be confirmed by independent approaches, e.g.
immunoelectron microscopy. Recently, a putative phosphate
transporter in bovine kidney peroxisomes has been studied by
using proteoliposomes containing peroxisomal membrane
proteins [51]. The liposomes were able to take up radioactive
phosphate although the Vmax of the reaction was not reached
even at the highest concentration of phosphate (50 mM). The
activity was not affected by known inhibitors of phosphate
transporters. These observations resemble results obtained
earlier on the similar experimental model although purified
peroxisomes were used instead of proteoliposomes [2]. The
uptake of carnitine, sucrose and other solutes by rat liver
peroxisomes did not follow saturation kinetics. This was
interpreted as a sign of the existence of peroxisomal channels.
Moreover, reconstitution of peroxisomal membrane proteins
into liposomes preloaded with radioactive sucrose led to leakage
of the solute implying insertion of pore-forming channels in the
artificial membrane [28].
2.3. Pore-forming channels in the peroxisomal membrane
Initial attempts to detect pore-forming activities in mamma-
lian peroxisomal preparations by using electrophysiological
analysis (single channel recording) have been made in the late
1980s [52,53]. Fusion of rat liver peroxisomal membranes to
planar lipid bilayers [52] as well as reconstitution of thismembrane or Triton X-100 solubilized peroxisomal integral
membrane proteins in liposomes followed by applying a patch
clamp technique [53] demonstrated incorporation of a large,
cation-selective voltage-dependent channels with an estimated
diameter 1.5–3.0 nm. The authors suggested that the physio-
logical role of these pore-forming channels is to allow the
exchange of substrates, products and cofactors for peroxisomal
enzymes between peroxisomal and cytosolic compartments.
The presence of pore-forming channels in mammalian and
yeast (see below) peroxisomes was later challenged (reviewed
in [54,55]). Apparently conflicting results describing peroxi-
somal membrane permeability (see Section 2.1) cast doubts on
the existence of active peroxisomal channels in vivo. The most
frequent objections refer to the high fragility of peroxisomes in
vitro and to the possibility that the functional regulation of
specific transporters may have been lost due to proteolytic
activity or dissociation of regulatory factors.
In addition to mammalian peroxisomes, pore-forming
activities were reported in peroxisomal preparations isolated
from yeasts [56] and plants [57–60]. A major 31 kDa integral
membrane protein of the yeast Hansenula polymorpha purified
to homogeneity was able to form pores after insertion into
liposomes preloaded with sucrose. The protein showed cross-
reactivity with antibodies against a 31 kDa voltage-dependent
anion channel (VDAC), called also porin, from the mitochon-
drial outer membrane of S. cerevisiae [56]. Interestingly, the
integral membrane proteins with sequence similarity to
mitochondrial porins were detected in the boundary membrane
of oilseed glyoxysomes [60]. These 34 kDa and 36 kDa proteins
reacted on immunoblots with antibodies raised against potato
tuber mitochondrial VDAC. Immunogold electron microscopy
confirmed that the anti-porin antibodies recognize antigens in
membranes of glyoxysomes and mitochondria. As a whole,
these data imply that the peroxisomal membrane, at least in
some species, may contain proteins structurally and functionally
homologous to the mitochondrial outer membrane porins. The
results, however, must be scrutinized from the point of view of
the purity of peroxisomal preparations. Our attempts to detect
porin-like proteins in highly purified rat or mouse liver
peroxisomes by using antibodies raised against human
VDAC1 and VDAC2 isoforms were without success [61].
Small anion-selective channels with single-channel con-
ductance 0.33–0.35 nS in 1 M KCl have been detected in
membranes of spinach leaf peroxisomes [57] and glyoxy-
somes of castor bean endosperm [58]. For comparison, the
porins of the outer membrane of mitochondria and plastids
(chloroplasts) are characterized by single channel conduc-
tance, 2–4 nS and 7–8 nS in 1 M KCl, respectively. The
channels of the two functionally different types of plant
peroxisomes, leaf peroxisomes and glyoxysomes, share
virtually identical basic properties, including similar single
channel conductance, a ratio of cation permeability to anion
permeability (pc/pa) of about 0.05 for KCl, the nonlinear
dependence of the single channel conductance on the KCl
concentration and a slight voltage dependence in 0.2 M KCl.
The porin-like channel of spinach leaf peroxisomes contains a
binding site specific for dicarboxylic acids which increases
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The authors predicted that plant peroxisomal channels enable
the passage of photorespiratory metabolites and intermediates
of the glyoxylate cycle, such as glycolate, glycerate, malate,
2-oxoglutarate and others [59]. It seems, however, that the
estimated diameter of plant peroxisomal channels (0.6 nm) is
too small to allow free movement of cofactors and ATP
across the membrane.
New data on mammalian membrane permeability to solutes
(Section 2.2, see also ref. [48]) prompted us reinvestigate
channel-forming activity in highly purified peroxisomal
preparations isolated from mouse liver [61]. Peroxisomal
membrane proteins solubilized by detergent were reconstituted
into a planar lipid bilayer. Single channel conductance
monitoring of the reconstituted artificial membranes revealed
at least two pore-forming activities with a conductance in 1 M
KCl of 1.3 nS and 2.5 nS. Additional pore-forming activities
were observed with conductance of 2.0 nS and 4.0 nS in 1.0 M
KCl may be caused by an admixture of mitochondrial porin in
its closed and open configurations, respectively. Indeed, the
frequency of 4.0 nS insertion events strongly correlates with the
purity of the peroxisomal preparations tested. In contrast, the
channel-forming activity with a conductance of 2.0 nS in 1 M
KCl was persistently detected in all peroxisomal preparations
independent of their purity. This may indicate the presence in
peroxisomal membranes of a third channel with a conductance
very similar to that of the mitochondrial porin in the closed
state.
The overall channel-forming activity in peroxisomal
preparations, which consisted mainly of the pore-forming
events with conductance 1.3 nS and 2.5 nS in 1 M KCl, did
not show voltage dependence. This observation favors the
presence of separate channels in the peroxisomal membrane
rather than one pore-forming protein in different functional
states like in the case of mitochondrial porin (voltage-
dependent gating) (reviewed in [62]). The peroxisomal
channel-forming activity is slightly cation-selective, with a
pc/pa ratio in KCl close to 4, which indicates that the
peroxisomal channels conduct about four times more potas-
sium than chloride; the conductance of the channels is linearly
dependent on the KCl concentration.
As a whole, the electrophysiological properties of the
mammalian peroxisomal membrane channels are clearly
different from those of the mitochondrial porins. The conduc-
tance of VDAC in the open configuration (4.0 nS in 1 M KCl)
[62] is much higher than that of the peroxisomal channels.
VDAC forms a large channel in the outer mitochondrial
membrane with an estimated diameter of 2.3–3.0 nm allowing
passage of small metabolites as well as ‘bulky’ solutes including
cofactors and ATP [62,63]. In contrast, VDAC in the closed
state, i.e. with a conductance of 2.0 nS in 1 M KCl, is imper-
meable to ATP [63]. The diameter of the largest peroxisomal
channel, i.e. with a conductance 2.5 nS in 1 M KCl, is likely
comparable with that of the mitochondrial porin in its closed
configuration. This may indicate that the peroxisomal channels
are specialized for the transfer of small solutes but do not allow
the physiologically relevant transmembrane movement ofcofactors and ATP. Indirect evidence (see Sections 3.3, 3.4)
favor this suggestion.
Some properties of mammalian peroxisomal channels might
explain difficulties with their detection by standard electro-
physiological procedures. The pore-forming activity is ex-
tremely unstable after solubilization of the membrane proteins
by detergent. The activity is reduced to near zero within a few
days storage at +4 °C. In addition, the rate of the channel-
forming activity is strictly dependent on the KCl concentration
in an aqueous phase surrounding the bilayer membrane, i.e. the
activity is higher when the KCl concentration in the chamber is
increased. Most probably, this feature of the peroxisomal
channels reflects a relatively high surface charge of the pore-
forming proteins, which prevents them from inserting into the
hydrophobic layer of an artificial membrane. Interestingly, the
previous reports describing peroxisomal pore-forming activities
were based on experiments where the conductance has been
measured at KCl concentrations in an aqueous phase of 0.1 M
KCl [49] and 0.3 M KCl [52], respectively. Under these
conditions one can expect quite a low frequency of the pore-
forming events characteristic for peroxisomal channels. The
large conductance and dependence on the voltage may indicate
that the pore-forming activities described in the reports [52,53]
result from the contaminating mitochondrial porins, which
show the same conductance in an open configuration.
Despite the growing experimental evidence for the presence
of pore-forming proteins in peroxisomal membranes, the
molecular nature of these channels has not yet been established.
This challenging task requires complex experimental ap-
proaches including purification of peroxisomal membrane
proteins, comprehensive electrophysiological studies of the
channel-forming activities, inactivation of the proteins to
establish their functional role in vivo and experiments on
isolated peroxisomes with deleted membrane proteins. This
work is in progress in our laboratory and in several other
groups.
2.4. The behavior of peroxisomes in vitro
The high fragility of peroxisomes under conditions usually
exploited in cell fractionation experiments is a well-known
phenomenon (see, for example, ref. [25–27]). As was shown
recently [64], during isolation, mammalian peroxisomes suffer
an osmotic lysis that is resistant to osmoprotectors such as
sucrose. This feature of the particles can be explained by the
high permeability of the peroxisomal membrane to small solutes
including sucrose and other commonly used osmoprotectors.
The osmotic damage to peroxisomes results in a transient
disruption of the membrane and leakage of soluble matrix
proteins. The smaller proteins escape more easily than the larger
ones from the broken particles. The membrane seals after
disruption restoring permeability properties and causing
formation of peroxisomal ‘ghosts’ with a poor content of low
molecular mass proteins. The damage to peroxisomes during
isolation can be partially prevented by using larger osmopro-
tectors that do not easily penetrate into the particles, e.g.
polyethylene glycol 1500 [64].
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The ‘two-channel’ concept (see Section 2.2) allows the
prediction of mechanisms involved in the transfer of solutes
across mammalian peroxisomal membranes. The ability of the
membrane to distinguish cofactors and other ‘bulky’ solutes,
e.g. ATP from small metabolites, implies that a separate pool of
cofactors (NAD/H, NADP/H, CoA and its acylated derivatives)
may be confined within peroxisomes, but common metabolites
are readily exchanged between the peroxisomal matrix and the
cytoplasm. As seen below, a variety of enzymatic activities are
exploited in peroxisomes to preserve a separate pool of
cofactors and at the same time to promote a constant flow of
small metabolites across the membrane.
3.1. Substrates and products of peroxisomal oxidases
In mammals a large set of H2O2-producing oxidases are
compartmentalized in peroxisomes. The H2O2 generated is then
converted to H2O and O2 by catalase, which is highly
concentrated in the peroxisomal matrix (reviewed in [19,65]).
Some oxidases metabolize CoA esters of fatty acids and bile
acid intermediates [19,20]. However, the bulk of the enzymes
oxidize small metabolites, which apparently cross the peroxi-
somal membrane easily by means of pore-forming channels.
This group of oxidases includes: urate oxidase [19,22,66], L-α-
hydroxyacid oxidases specific for hydroxyacids with different
chain lengths [67,68], D-amino acid and D-aspartate oxidases
[19,22,65,69], L-pipecolic acid (sarcosine) oxidase catalyzing
oxidation of L-pipecolic acid, sarcosine and L-proline [70], and
polyamine oxidase [71]. Some data also indicate that a portion
of xanthine oxidase/dehydrogenase is localized in rodent liver
peroxisomes [72,73]. As peroxisomal oxidases catalyze irre-
versible reactions, this will result in a local increase in the
concentration of the products of these reactions and a
corresponding decrease in the levels of the substrates inside
peroxisomes relative to the surrounding cytoplasm. Therefore,
one can expect the formation of concentration gradients along
peroxisomal channels that direct the import of the substrates
into peroxisomes and the export of the products out of the
particles.
3.2. Reactive oxygen species (ROS), glutathione enigma
The presence in peroxisomes of a large set of H2O2-
producing oxidases predicts an intensive generation of reaction
oxygen species (ROS) including, in addition to H2O2, singlet
oxygen (1O2), superoxide (O2·−) and hydroxyl (·OH) radicals.
This conclusion is indirectly supported by the fact that
mammalian peroxisomes are well equipped with the enzymes
of an antioxidant defense system. Besides catalase, the particles
contain CuZn- and Mn-dependent superoxide dismutases [74–
76], glutathione-S-transferase which shows also glutathione
peroxidase activity [77], epoxide hydrolase detoxifying pro-
ducts of lipid peroxidation [78] and peroxiredoxin, type V
[79,80]. The antioxidant potential of peroxisomes can be easily
demonstrated in vitro using measurements of the latency ofcatalase, which exceeds 80% of the total enzyme activity in the
particles [22,23,81]. The phenomenon reflects the extreme
efficiency of peroxisomes in the degradation of H2O2 owing to a
large particulate concentration of catalase, which is a very active
enzyme. Therefore, even rapid transfer of H2O2 across
peroxisomal membranes is not enough to saturate all the
catalase molecules in the particles. Our experiments with
proteinase K treatment of purified peroxisomes indicate that a
protein component (channel?) is responsible for the membrane
permeability to H2O2 [48].
The high concentration of catalase and other antioxidant
enzymes in peroxisomes in combination with a rapid flow of
H2O2 across the membrane may indicate that the particles form
an intracellular sink for ROS. On the other hand, easy diffusion
of H2O2 and perhaps other ROS out of the particles that is not
prevented by the membrane barrier may be dangerous for living
cells. Indeed, recent observations are in line with these
suggestions. For example, peroxisomal proliferation prevents
the neuronal cell death caused by Alzheimer's disease [82].
Mislocalization of peroxisomal catalase to the cytosol is
associated with an accumulation of H2O2 in cells [83] and
with seriously compromised neurological function in patients
[84]. Human hypocatalasemia is accompanied by accelerated
onset of age-related pathologies including type 2 diabetes,
atherosclerosis, cataracts, tumors and others [85,86]. All these
diseases are characterized by disturbances in ROS metabolism.
Glutathione (γ-glutamylcysteinylglycine, GSH) is the most
abundant cellular thiol and plays a central role in maintaining
cellular redox status and protecting cells from oxidative injury
[87,88]. The cellular concentration of this tripeptide with
molecular mass 307.3 Da is on the average 1-10 mM. GSH is
able to reduce peroxides and free radicals non-enzymatically
with the formation of oxidized glutathione (GSSG), which is a
hexapeptide with a molecular mass of 612.6 Da. GSSG is
reduced by the NADPH-dependent enzyme glutathione reduc-
tase. The enzyme was found in the cytoplasm and in
mitochondria [89]. Through the action of glutathione-S-
transferases, which are abundant in mammalian cells, GSH
participates in detoxification of a wide variety of compounds
including xenobiotics and products of lipid peroxidation. The
reaction results in the formation of glutathione conjugates with
toxic metabolites. These conjugates as well as GSH and GSSG
are exported across the cellular plasma membrane by members
of the ATP binding cassette superfamily of transport proteins
(ABC transporters) [90–92].
The participation of GSH in peroxisomal ROS metabolism
remains uncertain. The only indication of this role is the
peroxisomal localization of glutathione-S-transferase kappa
[77]. Apparently, GSH may easily pass the membrane by
peroxisomal channels. In contrast, the GSSG molecule is a
‘bulky’ solute. The size of GSSG may cause problems with its
transportation from peroxisomes. Interestingly, our attempts to
detect glutathione reductase activity in rodent liver peroxisomes
were without success (Antonenkov VD, unpublished data). This
raises a possibility that mammalian peroxisomes eliminate
GSSG by a mechanism that is not dependent on glutathione
reductase activity. One option is the removal of GSSG and
Fig. 1. Model of the shuttle and shunt mechanisms in mammalian peroxisomes.
(A) Mechanisms providing reduction of NADP+ and oxidation of NADH in
peroxisomes. Enzymes catalyzing the corresponding reactions: 1, glucose-6-
phosphate dehydrogenase; 2, NADP-dependent isocitrate dehydrogenase; 3,
lactate dehydrogenase; 4, NAD-dependent glycerol-3-phosphate dehydroge-
nase; 5, FAD-dependent glycerol-3-phosphate dehydrogenase (the enzyme is
localized on the outer surface of the inner mitochondrial membrane). The
putative peroxisomal membrane channels are shown here and on panel B as
brackets: ( ). (B) Carnitine-dependent shuttle mechanism. The enzymes
involved: 1, carnitine acetyltransferase; 2, carnitine octanoyltransferase. The
possible role of peroxisomal thioesterases in the transfer of acetyl/acyl groups
out of peroxisomes has been discussed elsewhere (Hiltunen et al., in this issue).
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resemble plasma membrane proteins carrying out a similar
function.
3.3. Peroxisomal shuttle systems
The β-oxidation of fatty acids and bile acid intermediates in
peroxisomes is accompanied by the reduction of NAD+ and the
formation of acetyl/acyl-CoA [19,20,93]. Some auxiliary
reactions of the β-oxidation, i.e. metabolism of unsaturated
fatty acids, require oxidation of NADPH [20,93]. This cofactor
is also important to prevent catalase inactivation by H2O2 [94].
The resulting compounds (NADH, NADP+ and acetyl/acyl-
CoA esters) are ‘bulky’ solutes unable to permeate peroxisomal
membranes fast enough to avoid accumulation in the particles.
Increasing evidence indicates that a number of shuttle systems
participate in the re-conversion of peroxisomal cofactors
without transporting them across the membrane. These
mechanisms resemble well-known mitochondrial shuttle sys-
tems. However, according to our ‘two-channel’ concept, the
important exception is an apparent participation of peroxisomal
membrane channels instead of specific transporters character-
istic of the inner mitochondrial membrane in the transmembrane
transfer of shuttle molecules.
Oxidation of peroxisomal NADH proceeds via lactate/
pyruvate and glycerophosphate shuttles owing to the localiza-
tion of a portion of lactate dehydrogenase [95] and NAD-
dependent glycerol-3-phosphate dehydrogenase [96] in mam-
malian peroxisomes (the bulk of these enzymes is present in the
cytoplasm) (Fig. 1A). NADH produced by peroxisomal β-
oxidation, transfers its electrons to pyruvate or DHAP, thus
reducing them to lactate and glycerol-3-phosphate, respectively.
These small solutes can easily pass the peroxisomal membrane
by channels. In the cytoplasm they are re-oxidized by the
corresponding dehydrogenases. Moreover, the glyceropho-
sphate shuttle may provide a direct flow of electrons from the
peroxisomal β-oxidation to the mitochondrial electron transport
chain via FAD-dependent glycerol-3-phosphate dehydrogenase
that is localized on the outer surface of the inner mitochondrial
membrane [97].
Reduction of NADP+ in peroxisomes is catalyzed by
glucose-6-phosphate dehydrogenase that has a dual localization,
i.e. cytoplasm and peroxisomes [30] and by NADP+-dependent
isocitrate dehydrogenase, which is present in peroxisomes as
well as in the cytoplasm and mitochondria [98] (Fig. 1A). Both
enzymes catalyze reactions that are irreversible under physio-
logical conditions. The products of these reactions do not
undergo re-conversion in the cytoplasm or mitochondria as in
the case of peroxisomal shuttles responsible for the NADH
oxidation (see above). Instead, these products are metabolized
further. Therefore, the peroxisomal localization of NADP+-
dependent dehydrogenases provides a shunt mechanism for
reduction of NADP+ in the particles.
Two carnitine acyltransferases: carnitine acetyltransferase
and carnitine octanoyltransferase, are located in the matrix of
mammalian peroxisomes (reviewed in [99]). The carnitine
octanoyltransferase is specific for medium chain fatty acids (thehexanoyl derivative is most preferred) [100]. As shown in Fig.
1B, the transferases convert the final products of peroxisomal β-
oxidation, acetyl-CoA and medium chain acyl-CoA's, into
carnitine esters which are more compact molecules when
compared with the corresponding acetyl/acyl-CoA esters.
Therefore, acetyl/acylcarnitines are able penetrate peroxisomal
membranes most probably by pore-forming channels and, as a
result, remove acetyl/acyl moieties from the particles. The
carnitine esters are then converted back to free carnitine and
acetyl/acyl-CoA derivatives by cytoplasmic carnitine acetyl/
1703V.D. Antonenkov, J.K. Hiltunen / Biochimica et Biophysica Acta 1763 (2006) 1697–1706acyltransferases or transported to mitochondria, where acetyl/
acyl groups are further oxidized to CO2 and H2O.
3.4. Peroxisomal nudix hydrolases
The transfer of ‘bulky’ solutes including cofactors and ATP
across the peroxisomal membrane is apparently accomplished
by specific transporters, which are discussed in detail in a
separate section of this issue. However, at least one unusual
mechanism described below obviates the need for transmem-
brane transporters in peroxisomes. Elimination of cofactors
from peroxisomes is important for several reasons including
regulation of their concentration in the particles and removal of
the damaged cofactor molecules. Therefore, peroxisomes have
to be equipped with specific mechanisms to carry out this
function. Most probably, removal of the cofactors from the
particles relies on the activity of enzymes called nudix
hydrolases. The nudix hydrolases form a diverse family of
proteins which predominantly hydrolyze a diphosphate (pyro-
phosphate) linkage in a variety of nucleotide containing
compounds [101]. At least three members of this family are
located in mammalian peroxisomes [102–104]. Two of them,
NUDT7p [102] and RP2p [104], react with CoA and some of its
derivatives. The third enzyme, NUDT12p, is a NAD(P)/H
diphosphatase [103]. The hydrolases cleave a pyrophosphate
linkage connecting two halves of the cofactor molecule, e.g. the
reaction catalyzed by NUDT12p is: NAD++H2O→NMN+
AMP. Therefore, the reaction products are approximately two
times smaller relative to the initial substrate. As a result, the
products of the cofactor degradation may cross the membrane
barrier apparently without the participation of specific trans-
porters but instead using peroxisomal channels. The peroxi-
somal nudix hydrolases show some preference for damaged
cofactors [105] implying that these enzymes play a role in
repairing the peroxisomal metabolic machinery.
4. Comments and conclusion
The current review combines well established results
available in the literature with some ideas that still need to be
confirmed. This combination has been chosen deliberately to
provide a comprehensive basis for new research on peroxisomal
membrane permeability. From the discussion it seems very
likely that the peroxisomal membrane is unique owing to the
unusual composition of proteins involved in the transfer of
metabolites, which include pore-forming channels side by side
with transporters specific for ‘bulky’ solutes and lipid
molecules. No doubts, the combination of channels and
transporters may create a highly efficient way to cope with
the extremely wide range of different metabolites that enter and
leave peroxisomes.
Little is known about the molecular nature of membrane
channels and transporters in peroxisomes. The only one
membrane protein with a known primary structure that has
been functionally characterized so far is the ATP/AMP antiporter
[39–41]. Currently we are still near the starting point of a long
road leading to an understanding of the molecular mechanismsresponsible for the permeability of peroxisomal membrane to
metabolites.
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